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Introduction. The surgical treatment of Gastric Cancer is associated with overall complication rates as high as 50%.  
The intent of this study was to assess the impact of epidural analgesia (EA) on postoperative complication rates among 
patients undergoing gastric resections.
Materials and methods. Of the 617 gastric cancer patients who between 2002 and 2010 had undergone stomach 
resection, 246 (39.8%) were administered EA. Groups with and without EA were compared. 
Results. The general rate of complications was lower in the EA group in the univariable analysis – 38.5% vs. 54.2% (odds ratio 
[OR]: 0.47, 95% confidence interval [CI]: 0.34–0.66, p < 0.001), intra-abdominal abscess (OR 0,28, 95% CI: 0.14–0.59, p = 0.001), 
pneumonia (OR 0,39, 95% CI: 0.24–0.63, p < 0.001), temperature >38°C (OR 0.53, 95% CI: 0.37–0.74, p < 0.001) and re-operation 
(OR 0.53, 95% CI: 0.28–1.00, p = 0.049). These relationships were confirmed in a multivariable analysis for the general number 
of complications (OR 0.53, 95% CI: 0.37–0.75, p < 0.001), intra-abdominal abscess (OR 0.36, 95% CI: 0.16–0.77, p = 0.009), 
temperature >38°C (OR 0.56, 95% CI: 0.39–0.82, p = 0.009), pneumonia (OR 0.42, 95% CI: 0.25–0.71, p = 0.001).
Conclusions. Our findings indicate that postoperative treatment with EA for patients undergoing stomach resection is 
safe and contributes to a reduction in the number of postoperative complications.
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Introduction 
For the past 100 years, cases of stomach cancer (gastric cancer 
– GC) amongst developed countries have been systemically in 
decline. Possible contributing factors for this decline may be attri-
buted to the increased use of refrigeration for food storage, dietary 
changes, and decreased incidents of infections with Helicobacter 
pylori [1]. Despite progress, stomach cancer remains the fourth 
most frequently diagnosed cancer worldwide. In 2008, there 
were 980,000 new cases, of which, 83,000 were reported in the 
European Union and over 5000 in Poland alone [1, 2]. In Poland, 
the 5-year survival rate post stomach cancer diagnosis is about 
18%, in Europe is about 25%, while in Japan about 70% [2–4].
Surgical resection of gastric cancer has produced subop-
timal survival rates despite multidisciplinary treatment appro-
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download 
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aches and improvements in surgical techniques. The European 
Society for Medical Oncology (ESMO) guidelines of treatment 
for patients diagnosed with an advanced GC include perio-
perative chemotherapy [5]. However, a total or subtotal ga-
strectomy with removal of the surrounding lymph nodes, (D2 
resection) remains the only curative method of treatment [5–8]. 
The vast extent of surgical intervention is one of the main con-
tributing factors to the high risk of complications associated 
with the procedure. The estimated number of complications 
varies between 17 and 48%. Additionally, gastric resection in 
conjunction with splenectomy or spleno-pancreatectomy 
significantly increases the potential for complications [9–14]. 
The management of quality care in postsurgical settings that 
include administration of regional analgesia contributes to 
better treatment outcomes [15, 16]. Due to the limitations in 
the use of opioids, resulting from the recommendations of the 
ERAS protocol, the effectiveness of epidural analgesia (EA) is 
very important. Currently, EA is a standard procedure in our 
team and for this reason historical data were compared. On the 
other hand, surgical procedures did not undergo significant 
modification during the period under review.
Objective
To assess the impact of EA on postoperative complication 
rates in patients undergoing subtotal or total gastrectomy 
for gastric cancer. 
Materials and methods
This study was conducted in a single institution using its ad-
ministrative database. All patients were treated between 2002 
and 2010 at The Maria Sklodowska-Curie Institute, Oncology 
Center in Warsaw. No neoadjuvant therapy was administered in 
the analyzed period. Of 723 GC resections performed, 617 cases 
had complete medical documentation that was adequate for 
retrospective review (study flow – fig. 1). 
The data of 617 patients diagnosed with gastric cancer 
that underwent resection of the stomach was retrospectively 
reviewed and analyzed by univariable and multivariable me-
thods. Patients were divided into two study groups based on 
the use of epidural analgesia and other methods. The group 
of patients treated without EA included patients who un-
derwent treatment during a period of time when epidural 
catheterization use was not the treatment of choice (until the 
end of 2006); these cases primarily occurred historically earlier 
than those who were treated with EA. Another reason for non 
EA administration was the lack of patient consent. Our study 
included 413 males (66.9%) and 204 females (33.1%) with a me-
dian age of 63 (53–71). Epidural analgesia was administered in 
246 patients (39.8%). The patients’ demographic and clinical 
characteristics are illustrated in table I and table II.
Analysis of the two group of patients indicated differences 
in the location of the gastric tumor, the extent of the gastric 
resection, and spleen removal. Patients treated without EA 
more frequently experienced malnutrition (BMI < 19). We did 
not observe statistically significant differences among both 
studied groups in respect to demographic characteristics, 
pre-operative risk factors (excluding hypertension), and the 
length of the procedure. The statistical univariable and mul-
tivariable analysis of the factors contributing to postsurgical 
complications included:
• administered EA, 
• gender, 
• age, 
• pre-surgical BMI, 
• diabetes, 
• hypertension, 
Table I. Baseline characteristics – demographic data, nutrition status, and 
comorbidities
Characteristic Epidural analgesia (EA) p value
No
n = 371 (%)
Yes



























comorbidities 296 (61.0) 189 (39.0) 0.381
diabetes 28 (54.9) 23 (45.1) 0.426
coronary disease 107 (60.1) 71 (39.9) 0.996
hypertension 125 (53.6) 108 (46.4) 0.010
peptic ulcer 93 (64.1) 52 (35.9) 0.260
anemia 304 (58.6) 215 (41.4) 0.069
EA – epidural analgesia; IQR – interquartile range
satisfied exclusion  
and inclusion criteria  
n = 723
complete data  
available 
n = 617
complete data  
not available 
n = 106
pain managemente  
with EA 
n = 246
pain managemente  
without EA 
n = 371
Figure 1. Flow-chart of the study
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• coronary disease, 
• and peptic ulcers. 
Additionally, in our analysis we included perioperative 
transfusions, the length of the surgery, and the extent of the 
multi-organ resection.
Operative treatment
All cases included in this study contained patients who were 
operated on by the same experienced (over 30 operations 
per surgeon) surgical team. Post-operative care and manage-
ment was provided using consistent post-surgical protocols 
that included enteral and parenteral nutrition for a period of 
7 to 10 days. Total gastrectomy (TG) was performed on 321 
patients (52%), 174 (28.2%) patients were treated with TG 
expanded by resection of the lower section of the esophagus, 
110 (17.85%) patients underwent distal subtotal gastrectomy 
(SG), and in 6 (1%) of these cases proximal gastrectomy (PG) 
was performed.  In 434 (70.3%) of these cases, surgery was 
performed by laparotomy, in 183 (29.7%) patient’s a laparo-
tomy was performed via the thoraco-abdominal approach. 
We performed curative gastrectomies and dissections of the 
lymph nodes expanded by removal of the additional organs 
in cases rendering more extensive surgical interventions. 
The range of surgical resections in both groups of patients 
is presented in table II.
Postoperative pain management
All patients (from 2007) were preoperatively evaluated for the 
postoperative use of epidural analgesia. Additionally, patients 
that were administered epidural analgesia consented to the 
procedure in a separate preoperative assessment. We admini-
stered EA in all suitable cases, except in patients with clinical 
contraindications to the procedure, and in cases where the 
patient did not consent. Contraindications included: 
• coagulation disorders or perioperative use of blood clot-
ting medications, 
• inflammation at the catheter placemat area, 
• neurological conditions. 
Prior to administering general anesthesia, in the operating 
room, the epidural catheter was placed into the epidural space 
between Th6 and Th7 (when the patient’s anatomy dicta-
ted, exact vertebral space varied by one up/down segments). 
The  area designated for catheter placement was prepared 
according to surgical protocols, with the insertion site disin-
fected and surgical dressing administered.  The skin and the 
subcutaneous tissue in the puncture site was anesthetized 
with a  2% solution of lidocaine and kept sterile. After the 
catheter was inserted into the epidural space, it was secured 
on the skin surface with clearly marked transparent dressing 
tape. Our postoperative pain management regimen of choice 
was epidural analgesia, administered via continuous infusion 
of Breivik’s mixture into the epidural space using a syringe 
pump [17]. The mixture was composed of low concentrations 
of medications (22 µg/ml adrenaline, 2 µg/ml fentanyl and 
1.25 mg/ml bupivacaine – which deviates slightly from the 
standard regimen) in a 0.9% solution of sodium chloride. The 
epidural infusion delivery rate was about 3:9 ml/h. Patients in 
both studied groups were intravenously administered coanal-
Table II. Type and extent of surgical intervention
Epidural analgesia (EA) p value 
No
n = 371 (%)
Yes











• TG + distal esophagostomy
• distal resection (SG)



























perioperative blood transfusion 147 (39.6) 72 (29.3) 0.008
neighboring organ resection 178 (48.0) 110 (44.7) 0.426
splenectomy 138 (37.2) 65 (26.4) 0.005
distal pancreatectomy 15 (4.0) 6 (2.4) 0.282
large bowel resection 6 (1.6) 7 (2.8) 0.298
cholecystectomy 29 (7.8) 14 (5.7) 0.310
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gesics (metamizol and paracetamol). Patients that were not 
postoperatively administered EA received a subcutaneously 
delivered morphine sulfate in fractionated doses (5–10 mg/
dose) in 4–6 hour intervals, accompanied with coanalgesics.  
Statistical analysis
Information collected throughout our research was recorded, 
analyzed, and presented in tables with a cross-tabulation of 
data. The operative time and age are divided into four catego-
ries based on quartiles. The Chi2 test and Wilcoxon test were 
used to compare the groups. The relationship between po-
stoperative complications (outcomes) and the use of epidural 
analgesia is analyzed in a univariable logistic regression model 
and in a multivariable logistic regression model that controls 
for confounders. Multi-step forward regression was used to 
select significant disturbing variables in multivariate models, 
including significant variables at <0.1 (the multiple variables 
describing the EA was included in each model regardless of 
its significance level). The results of the models are presented 
in the form of odds ratios (OR) and 95% confidence intervals 
(CI). Variables for which p < 0.05 were considered significant. 
This analysis is performed with Stata software, version 13.1 
(Stata Corporation, College Station, Texas, USA).
Bioethics  
The study was conducted in compliance with the Declaration 
of Helsinki for medical research and was approved by the 
Local Bioethics Committee at The Maria Sklodowska-Curie 
Institute, Oncology Center in Warsaw (permit No. 20/2017 
from 09.02.2017). As a retrospective study, according to the 
approval of the bioethical committee, the informed consent 
of the patient was not required.
Results
There were no EA-related complications (neurological deficits, 
postdural puncture headache), although not every patient 
managed to insert an epidural catheter. Patients who did not 
have an epidural catheter inserted for technical reasons were 
analyzed in the group without EA. Administration of epidural 
catheters or epidural analgesia is not associated with incre-
ased risk for postoperative complications.  The postoperative 
mortality rate was 1%, (6 patients of 617). No thromboembolic 
or pulmonary complications were present amongst postope-
rative patients who had received EA. Due to an insignificant 
occurrence rate, we did not review incidents of hemoperito-
neum (intra-abdominal leak), postoperative eventration, or 
cases of anastomotic strictures (tab. III).
Additionally, the univariable analysis of patients that were 
administered EA displayed a lower frequency of postoperative 
complications compared to the group treated with other me-
thods (OR 0.47, 95% CI: 0.34–0.66, p < 0.001), intra-abdominal 
abscesses (OR 0.28, 95% CI: 0.14–0.59, p = 0.001), pneumonia 
(OR 0.39, 95% CI: 0.24–0.63, p < 0.001), temperature >38ºC (OR 
0.53, 95% CI: 0.37–0.74, p < 0.001) and reoperations (OR 0.53, 
95% CI: 0.28–1.00, p = 0.049) (fig. 2).
These relationships were confirmed in a multivariable 
analysis for the general number of complications (OR 0.53, 95% 
CI: 0.37–0.75, p < 0.001), intra-abdominal abscess (OR 0.36, 95% 
CI: 0.16–0.77, p = 0.009), temperature >38ºC (OR 0.56, 95% CI: 
0.39–0.82, p = 0.009), pneumonia (OR 0.42, 95% CI: 0.25–0.71, 
p = 0.001) – tables: IV, V and VI. The relationship between 
administering EA and reoperation in a multivariable analysis 
was not confirmed. Diagnosis of pneumonia was based on 
the correlation of clinical symptoms and radiological deter-
minations. There were no significant statistical differences in 
univariable and multivariable analysis of wound infections, 
infection of the central line, or the anastomotic stricture, 
(table VI and table VII). 
Discussion
Complications associated with gastrectomy with D2 lym-
phadenectomy for the treatment of gastric cancer presents 
multiple clinical considerations against extensive lympha-
denectomy [10, 13, 14]. The overall rate of complications is 
between 17 to 48%. The most frequent postoperative com-
plications in gastric resection surgeries for curative gastric 
Table III. Postoperative complications
Complication type Epidural analgesia (EA)
No
n = 371 (%)
Yes
n = 246 (%)
overall complications (total) 201 (54.2) 88 (35.8)
temperature >38ºC 158 (42.6) 69 (28)
pneumonia 81 (21.8) 24 (9.8)
intra-abdominal abscess 44 (11.9) 9 (3.7)
anastomotic leak 40 (10.8) 20 (8.1)
re-operation 38 (10.2) 14 (5.7)
wound infections 28 (7.5) 13 (5.3)
catheter related sepsis                             28 (7.5) 17 (6.9)
anatomic stricture 6 (1.6) 1 (0,4)
intra-abdominal bleeding 4 (1.1) 4 (1.6)
eventration 2 (0.5) 1 (0.4)
0.0 1.0






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































cancer interventions are pneumonia, surgical site infections, 
(incision infections, intra-abdominal abscesses) and leaking 
anastomosis [9–14, 18]. Despite the potential for postoperative 
complications, extensive surgical resection with lymph nodes 
dissection remains the only curative therapy for gastric cancer 
worldwide. Experienced medical institutions specializing in 
surgical oncology routinely perform extensive curative resec-
tions for gastric cancer [9, 10, 14, 19].   
Effective analgesia is an essential part of postsurgical ma-
nagement and provides statistically and clinically significant 
improvements in treatment outcomes. Most published cli-
nical studies have demonstrated that the administration of 
epidural analgesia in gastric surgery patients is a safe practice 
as a means to improve perioperative outcomes [16, 20–24]. 
Effective postoperative pain management, as well as the re-
duction of stress response to surgery along with management 
of the cardiovascular system and microcirculation significantly 
reduces complications. Furthermore, studies suggest that ad-
ministering EA contributes to the reduction of perioperative 
blood loss. The recommended technique requires continuous 
infusion of pain medications assisted by intermitted bolus 
injections [25, 26].   
A comprehensive literature review of the effect of po-
stoperative analgesia on surgical outcomes [24] showed the 
impact of administering epidural analgesia on complications 
rates following major abdominal surgery. Throughout this 
study, authors established that the administration of epidu-
ral analgesia significantly reduces the risk of pulmonary and 
cardiovascular complications, as well as thromboembolism, 
postoperative occlusions, and hastens the return of bowel 
function. Our study was performed retrospectively and is 
therefore subject to associated biases. During the extensive 
research period in which the review of this data occurred, 
our standards of postoperative care and surgical experience 
have improved; possibly affecting our findings had this data 
included newer cases. Therefore, based on this study alone, we 
cannot definitively conclude that administering EA decreases 
the risk of complications after gastrectomy. There is, however 
increasing evidence of the overall positive impact that EA has 
on treatment outcomes. When considering the retrospective 
review of 84 patients that underwent laparoscopic SG [27], all 
data suggests that administering EA has no significant impact 
on treatment outcomes, except for patients treated with EA 
who experienced urinary retention.  
In a prospective study of 1021 patients, the analysis con-
firmed more effective pain management, a lower need for 
analgesics, and a shorter stay in the intensive care unit [28]. 
No statistically significant differences were reported for mor-
tality and the postoperative complication rate. Further analysis 
demonstrated a reduction of postoperative complications 
in the group of patients administered EA that underwent 
vascular surgical interventions. In the relatively smaller groups 
of patients that underwent gastrectomy (77 patients), large 
intestine or bile duct operation, the difference between the 
number of postoperative complications remains insignificant. 
The results of the Cochrane Database analysis [29] in which 
94 studies were evaluated, (total of 5864 patients) suggests 
effective pain management and an accelerated return of ga-
strointestinal transit in patients treated with EA. With the use 
of the open surgery technique, EA reduces the length of the 
hospital stay. There was no difference in vomiting incidence or 
anastomotic leak. Complications of epidural analgesia are rare, 
but additional studies to examine the impact of administering 
epidural analgesia in extensive surgical interventions for gastric 
cancer are needed. 
A recently publish retrospective review of the American 
College of Surgeons National Surgical Quality Improvement 
Program [30] performed for patients undergoing open elective 
esophagectomies and gastrectomies for nonmetastatic cancer, 
analyzed a group of 2599 gastrectomies, among which 18% 
received EA. The only conclusion from the analysis is that EA 
was associated with a longer length of stay (EA median [IQR] 
8 [7, 11] vs. no EA 7 [6, 11], p = 0.0002). No other differences 
between the groups were noted.
Of the retrospective review of 723 gastric cancer resections 
performed at our institution, 617 cases had complete medical 
documentation that was adequate for review (85.3%). Data not 
included in this study amounting to the remaining 14.7% of 
cases was excluded due to random issues such as incomplete 
medical records and other associated factors. The analyzed 
group of patients was treated with comparable surgical tech-
niques, postoperative care, and perioperative management 
protocols. Patients administered EA did not experience a higher 
number of complications than the group of patients treated 
with other methods. Thus, administering EA has proven to be 
safe in the perioperative care of patients undergoing gastric 
resection. Research indicates that the frequency of wound 
infections (fever > 38°C, intra-abdominal abscess) pneumonia 
and reoperations is reduced in the group of patients with EA. 
Metaanalysis [26] as well as our assessments confirm that 
effective postoperative pain management decreases the in-
cidence of pulmonary complications. We observed a decre-
ased number of other complications, (except for frequency 
of anastomotic leak), however in conclusion, they offer no 
statistical significance.
Conclusions
Our findings indicate that administering EA to patients un-
dergoing major stomach resection for gastric cancer is safe. 
Furthermore, postoperative treatment with epidural analgesia 
following stomach resection contributes to a reduction in the 
number of postoperative complications; this is most notable 
in the reduced number of cases of pneumonia, sepsis, and the 
need for additional surgical interventions.
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